• Something wrong with this record ?

Is the small size of a breast cancer tumor the crucial point for successful medical treatment

M. Strunová, D. Pavlišta, J. Kobilková, J. Pokorný, M. Janoušek, L. Bauerová, A. Jandová

. 2014 ; 115 (3-4) : 134-140.

Language English Country Czech Republic

Document type Case Reports, Journal Article

The presented case displays a clinical study of a cancer phenotype with a poor clinical outcome. Prediction of cancer development and effects of treatment at the beginning of the clinical stage is difficult as the knowledge of cancer process and all necessary parameters of the host body are limited. Cancer is mainly studied on the basis of biochemical-genetic processes and their morphological manifestation. However, the malignant process is assumed to be of essential biophysical nature and develops after mitochondrial dysfunction, which is a direct result of oncogene mutation. Cancers based on the normal and the reverse Warburg effect should be distinguished. The cancer tumors with the reverse Warburg effect display aggressiveness associated with a high rate of recurrence and metastatic implantation. Besides the nature of the two basic types of breast cancer tumors the outcome depends not only on their type, size, and site but also on reactions and interaction with the surrounding tissue and the body aptitude for metastatic activity connected with individual blood or lymphatic vessels for metastatic transport. It is necessary to assess all favourable and adverse factors for cancer development. General reliable method of their specification for all cancers is not available. Nevertheless, the main factor seems to be aggressiveness of cancer cells as follows from interpretation. To reveal the aggressive reverse Warburg effect tumors, metabolic biomarkers of the fibroblast stress should be examined.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15019777
003      
CZ-PrNML
005      
20150818110137.0
007      
ta
008      
150611s2014 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/23362936.2014.44 $2 doi
035    __
$a (PubMed)25626332
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Strunová, Marie $u Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 xx0143592
245    10
$a Is the small size of a breast cancer tumor the crucial point for successful medical treatment / $c M. Strunová, D. Pavlišta, J. Kobilková, J. Pokorný, M. Janoušek, L. Bauerová, A. Jandová
520    9_
$a The presented case displays a clinical study of a cancer phenotype with a poor clinical outcome. Prediction of cancer development and effects of treatment at the beginning of the clinical stage is difficult as the knowledge of cancer process and all necessary parameters of the host body are limited. Cancer is mainly studied on the basis of biochemical-genetic processes and their morphological manifestation. However, the malignant process is assumed to be of essential biophysical nature and develops after mitochondrial dysfunction, which is a direct result of oncogene mutation. Cancers based on the normal and the reverse Warburg effect should be distinguished. The cancer tumors with the reverse Warburg effect display aggressiveness associated with a high rate of recurrence and metastatic implantation. Besides the nature of the two basic types of breast cancer tumors the outcome depends not only on their type, size, and site but also on reactions and interaction with the surrounding tissue and the body aptitude for metastatic activity connected with individual blood or lymphatic vessels for metastatic transport. It is necessary to assess all favourable and adverse factors for cancer development. General reliable method of their specification for all cancers is not available. Nevertheless, the main factor seems to be aggressiveness of cancer cells as follows from interpretation. To reveal the aggressive reverse Warburg effect tumors, metabolic biomarkers of the fibroblast stress should be examined.
650    _2
$a nádory prsu $x patologie $x terapie $7 D001943
650    _2
$a duktální karcinom prsu $x patologie $x terapie $7 D018270
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    12
$a tumor burden $7 D047368
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pavlišta, David $u Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 xx0057882
700    1_
$a Kobilková, Jitka, $u Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $d 1928- $7 jk01060899
700    1_
$a Pokorný, Jiří $u Institute of Photonics and Electronics, Academy of Sciences of the Czech Republic, Prague, Czech Republic $7 xx0070551
700    1_
$a Janoušek, Miloslav $u Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 xx0101762
700    1_
$a Bauerová, Lenka $u Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 xx0240645
700    1_
$a Jandová, Anna $u Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 xx0073941
773    0_
$w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 115, č. 3-4 (2014), s. 134-140
856    41
$u https://pmr.lf1.cuni.cz/media/pdf/pmr_2014115030134.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 7 $c 1071 $y 4 $z 0
990    __
$a 20150611 $b ABA008
991    __
$a 20150818105118 $b ABA008
999    __
$a ok $b bmc $g 1087885 $s 902725
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 115 $c 3-4 $d 134-140 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
LZP    __
$b NLK118 $a Pubmed-20150611

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...